BioRestorative Therapies (BRTX) Other Non-Current Assets (2011 - 2019)
BioRestorative Therapies' (BRTX) quarterly Other Non-Current Assets came in at $22100.0 in Q3 2019, little changed YoY from $22100.0 in Q3 2018, and little changed on a QoQ basis from $22100.0 in Q4 2018.
BioRestorative Therapies (BRTX) Other Non-Current Assets (2011 - 2019) Analysis & Trends
BioRestorative Therapies (BRTX) has 8 years of Other Non-Current Assets data on file, last reported at $22100.0 in Q3 2019.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $22100.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $22100.0 (changed 0.0% YoY) and the FY2018 annual result came in at $22100.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $22100.0 in Q3 2019, from $22100.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $45900.0 in Q1 2015 to a low of $22100.0 in Q4 2017.
- A 5-year average of $34044.0 and a median of $34176.0 in 2016 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2015 — Other Non-Current Assets changed 0.0% — and 2017, when it tumbled 35.33%.
- Tracing BRTX's Other Non-Current Assets over 5 years: stood at $45900.0 in 2015, then retreated by 25.54% to $34176.0 in 2016, then plunged by 35.33% to $22100.0 in 2017, then changed by 0.0% to $22100.0 in 2018, then changed by 0.0% to $22100.0 in 2019.
- The last three Other Non-Current Assets figures came in at $22100.0 (Q3 2019), $22100.0 (Q4 2018), and $22100.0 (Q3 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 22,100.00 |
| Dec 31, 2018 | 22,100.00 |
| Sep 30, 2018 | 22,100.00 |
| Jun 30, 2018 | 22,100.00 |
| Mar 31, 2018 | 22,100.00 |
| Dec 31, 2017 | 22,100.00 |
| Sep 30, 2017 | 34,176.00 |
| Jun 30, 2017 | 34,176.00 |
| Mar 31, 2017 | 34,176.00 |
| Dec 31, 2016 | 34,176.00 |
| Jun 30, 2016 | 45,900.00 |
| Mar 31, 2016 | 45,900.00 |
| Dec 31, 2015 | 45,900.00 |
| Sep 30, 2015 | 45,900.00 |
| Jun 30, 2015 | 45,900.00 |
| Mar 31, 2015 | 45,900.00 |
| Dec 31, 2014 | 45,900.00 |
| Sep 30, 2014 | 45,900.00 |
| Sep 30, 2012 | 4,415.00 |
| Jun 30, 2012 | 4,415.00 |